COMMUNIQUÉS West-GlobeNewswire

Plum Tree Launches New Chronic Illness Therapy Program
29/10/2025
ST. CHARLES, Ill., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Plum Tree Psychology, Ltd., a leading child and family mental health practice in the Fox Valley, today announced the launch of Hoot & Holler, a new Chronic [...]
Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Phase III trials
29/10/2025
NEPTUNUS-1 and NEPTUNUS-2 achieved primary objective of reduced disease activity and provided clinically meaningful benefit 1 Data showed consistent improvements across secondary outcome measures, and a favorable safety [...]
MEDIROM to Launch New Treasury Strategy Utilizing Cryptocurrency
29/10/2025
Aimed at incentivize large-scale vital data collection TOKYO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc., (Headquarters: Minato-ku, Tokyo; President and CEO: Kouji Eguchi; listed on the [...]
OXB honoured at 2025 CDMO Leadership Awards Europe in ‘Cell & Gene Therapy’ category
29/10/2025
Oxford, UK – 29 October 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces it has been recognised as a Champion in the ‘Cell & Gene Therapy’ category at the 2025 [...]
FDA Grants Orphan Drug Designation to Dewpoint Therapeutics’ DPTX3186 for the Treatment of Gastric Cancer
29/10/2025
First orphan designation ever granted to a condensate-modulating therapeutic Builds on recent IND opening for DPTX3186, a first-in-class oral condensate modulator targeting the Wnt/ β -catenin pathway Provides key [...]
Betterguards Launches The BetterGuard Lite, a Powerful New Ankle Protection System with Breakthrough Design
29/10/2025
The BetterGuard Lite features an impossibly thin, lightweight design at an affordable price for athletes worldwide NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Betterguards , a sports technology innovator, today [...]
Bioxytran Completes Randomized Clinical Trial For its Broad-Spectrum Antiviral Drug
29/10/2025
Data from the dose optimization trial expected soon ProLectin-M is positioned as the first oral antiviral sugar chemistry drug BOSTON, MASSACHUSETTS, Oct. 29, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the [...]
Anaptys Announces New Positive Phase 2b Trial Results for Rosnilimab in Rheumatoid Arthritis at ACR Late-Breaking Oral Presentation
29/10/2025
New data reinforce rosnilimab’s efficacy profile in rheumatoid arthritis (RA) with deepening of clinical responses, including CDAI remission, from Week 12 to Week 28 regardless of prior advanced therapy, including JAKs [...]
MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
29/10/2025
SAN FRANCISCO and BOSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous [...]
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds
29/10/2025
PHOENIX, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. , (Nasdaq: CELZ) (the “Company”), a clinical-stage biotechnology company pioneering regenerative immunotherapy, today announced that [...]
Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation to Active Capital Market Operations
29/10/2025
LITS Board of Directors Reaffirms Commitment to Driving Long-Term Stockholder Value SAN DIEGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Lite Strategy, Inc. (NASDAQ: LITS) (“Lite Strategy” or “LITS”) today announced its Board [...]
National Survey Reveals Persistent Gaps in Pediatric Care Experiences Among U.S. Families
29/10/2025
Zarminali Pediatrics releases data emphasizing the need for more connected, coordinated care CHICAGO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Zarminali Pediatrics , the first outpatient pediatric destination purpose-built to [...]
Vivian Health Partners with Hallmark to Power Faster, Smarter Hiring
29/10/2025
New integration connects Vivian, the largest healthcare talent marketplace, with Hallmark’s Workforce Intelligence and Enablement Platform—streamlining travel nurse and allied health clinician placements. SAN FRANCISCO [...]
Solana Company Announces Updated SOL Holdings and Industry Leading Staking Yield
29/10/2025
NEWTOWN, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”) today announced its updated Solana (“SOL”) token and cash holdings as of Oct. 29 at 12:00 am ET, as well as its [...]
I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform
29/10/2025
New corporate brand reflects strategic transformation to a global biotech platform accelerating access to innovative medicines for patients worldwide Strategy centers on broadening access to global capital and [...]
Aeroflow Health and UnitedHealthcare Partner to Deliver Virtual Nutrition Services Nationwide
29/10/2025
The partnership enables UnitedHealthcare to integrate telehealth nutrition services across Commercial and Medicare plans to enhance patient wellness ASHEVILLE, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Aeroflow Health , a [...]
PDS Biotech to Seek Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer
29/10/2025
Company aims to shorten time frame to make PDS0101 available to patients with HPV16-positive head and neck cancer, projected to be the most dominant type of head and neck cancer in the US by mid 2030s Proposed Amendment [...]
Moleculin Expands Global IP Portfolio with New Australian Patent for Annamycin
29/10/2025
HOUSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat [...]
PolarityBio Announces Acceptance of Category III CPT® Code Application for Autologous Heterogeneous Skin Construct Graft by AMA CPT® Editorial Panel
29/10/2025
Secured Category III CPT Codes Pave the Way for Broader Access to Regenerative Skin Construct SALT LAKE CITY, Oct. 29, 2025 (GLOBE NEWSWIRE) -- PolarityBio , a clinical-stage biotechnology company focused on addressing [...]

Pages